GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity.
Falk S, Petersen J, Svendsen C, Romero-Leguizamón CR, Jørgensen SH, Krauth N, Ludwig MQ, Lundø K, Roostalu U, Skovbjerg G, Nielsen DAG, Ejdrup AL, Pers TH, Dmytriyeva O, Hecksher-Sørensen J, Gether U, Kohlmeier KA, Clemmensen C.
Falk S, et al. Among authors: lundo k.
Cell Rep. 2023 May 30;42(5):112466. doi: 10.1016/j.celrep.2023.112466. Epub 2023 May 5.
Cell Rep. 2023.
PMID: 37148870
Free article.